Clinical Trial Update: Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal Function [Phase 1]

View source ↗

Summary

Phase 1, single-dose pharmacokinetic study comparing pretomanid in participants with renal impairment to those with normal renal function; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Pretomanid (pretomanid)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Renal Impairment, Tuberculosis | Phase 1 | Status: COMPLETED | Results posted: 2025-10-15